Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA.

Ann Rheum Dis. 2020 Feb;79(2):225-231. doi: 10.1136/annrheumdis-2019-216030. Epub 2019 Nov 9.

PMID:
31707357
2.

Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.

Son MBF, Gauvreau K, Tremoulet AH, Lo M, Baker AL, de Ferranti S, Dedeoglu F, Sundel RP, Friedman KG, Burns JC, Newburger JW.

J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.

3.

Pediatric CNS-isolated hemophagocytic lymphohistiocytosis.

Benson LA, Li H, Henderson LA, Solomon IH, Soldatos A, Murphy J, Bielekova B, Kennedy AL, Rivkin MJ, Davies KJ, Hsu AP, Holland SM, Gahl WA, Sundel RP, Lehmann LE, Lee MA, Alexandrescu S, Degar BA, Duncan CN, Gorman MP.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 8;6(3):e560. doi: 10.1212/NXI.0000000000000560. eCollection 2019 May.

4.

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.

Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA.

Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. doi: 10.1186/s12969-019-0309-6.

5.

Disrupted N-linked glycosylation as a disease mechanism in deficiency of ADA2.

Lee PY, Huang Y, Zhou Q, Schnappauf O, Hershfield MS, Li Y, Ganson NJ, Sampaio Moura N, Delmonte OM, Stone SS, Rivkin MJ, Pai SY, Lyons T, Sundel RP, Hsu VW, Notarangelo LD, Aksentijevich I, Nigrovic PA.

J Allergy Clin Immunol. 2018 Oct;142(4):1363-1365.e8. doi: 10.1016/j.jaci.2018.05.038. Epub 2018 Jun 21. No abstract available.

6.

Association Between Dose of Glucocorticoids and Coronary Artery Lesions in Kawasaki Disease.

Okubo Y, Michihata N, Morisaki N, Sundel RP, Matsui H, Fushimi K, Yasunaga H.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1052-1057. doi: 10.1002/acr.23456. Epub 2018 May 22.

7.

Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores.

Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, Lo MS, Baker AL, Sundel RP, Newburger JW.

J Am Heart Assoc. 2017 May 31;6(6). pii: e005378. doi: 10.1161/JAHA.116.005378.

8.

National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.

Okubo Y, Nochioka K, Sakakibara H, Testa M, Sundel RP.

Clin Rheumatol. 2017 Feb;36(2):413-419. doi: 10.1007/s10067-016-3512-6. Epub 2016 Dec 16.

PMID:
27987089
9.

Evidence-based decision support for pediatric rheumatology reduces diagnostic errors.

Segal MM, Athreya B, Son MB, Tirosh I, Hausmann JS, Ang EY, Zurakowski D, Feldman LK, Sundel RP.

Pediatr Rheumatol Online J. 2016 Dec 13;14(1):67.

10.

Nationwide epidemiological survey of childhood IgA vasculitis associated hospitalization in the USA.

Okubo Y, Nochioka K, Sakakibara H, Hataya H, Terakawa T, Testa M, Sundel RP.

Clin Rheumatol. 2016 Nov;35(11):2749-2756. Epub 2016 Sep 5.

PMID:
27596741
11.

Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.

Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD.

Arthritis Rheumatol. 2016 Jul;68(7):1758-68. doi: 10.1002/art.39606.

12.

Kawasaki disease.

Sundel RP.

Rheum Dis Clin North Am. 2015;41(1):63-73, viii. doi: 10.1016/j.rdc.2014.09.010. Review.

PMID:
25399940
13.

Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management.

Shakti D, Hehn R, Gauvreau K, Sundel RP, Newburger JW.

J Am Heart Assoc. 2014 Nov 7;3(6):e001483. doi: 10.1161/JAHA.114.001483.

14.

Pain hypersensitivity in juvenile idiopathic arthritis: a quantitative sensory testing study.

Cornelissen L, Donado C, Kim J, Chiel L, Zurakowski D, Logan DE, Meier P, Sethna NF, Blankenburg M, Zernikow B, Sundel RP, Berde CB.

Pediatr Rheumatol Online J. 2014 Sep 6;12:39. doi: 10.1186/1546-0096-12-39. eCollection 2014.

15.

Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors.

Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic DS, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance (CARRA).

J Rheumatol. 2014 Jun;41(6):1163-70. doi: 10.3899/jrheum.131503. Epub 2014 May 1.

PMID:
24786928
16.

Hypergammaglobulinemia in the pediatric population as a marker for underlying autoimmune disease: a retrospective cohort study.

Lo MS, Zurakowski D, Son MB, Sundel RP.

Pediatr Rheumatol Online J. 2013 Nov 1;11(1):42. doi: 10.1186/1546-0096-11-42.

17.

Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.

Kentsis A, Shulman A, Ahmed S, Brennan E, Monuteaux MC, Lee YH, Lipsett S, Paulo JA, Dedeoglu F, Fuhlbrigge R, Bachur R, Bradwin G, Arditi M, Sundel RP, Newburger JW, Steen H, Kim S.

EMBO Mol Med. 2013 Feb;5(2):210-20. doi: 10.1002/emmm.201201494. Epub 2012 Dec 20.

18.

Pediatric chronic nonbacterial osteomyelitis.

Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, Sundel RP.

Pediatrics. 2012 Nov;130(5):e1190-7. doi: 10.1542/peds.2011-3788. Epub 2012 Oct 15.

PMID:
23071213
19.

Paediatric rheumatic disease: Classification warfare.

Sundel RP.

Nat Rev Rheumatol. 2012 Oct;8(10):570-2. doi: 10.1038/nrrheum.2012.151. Epub 2012 Sep 18.

PMID:
22986458
20.

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.

Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M, Kim S, Adamczyk B, Rudd PM, Son MB, Sundel RP, Foell D, Glass DN, Thompson SD, Nigrovic PA.

Arthritis Rheum. 2012 Sep;64(9):3025-33. doi: 10.1002/art.34507.

21.

Putting collagen back in the collagen vascular disorders.

Sundel RP.

Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v60-2. doi: 10.1093/rheumatology/ker398. Review. No abstract available.

PMID:
22210672
22.

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O'Neil KM, Zeft AS, Szer IS, Ringold S, Brunner HI, Schanberg LE, Sundel RP, Milojevic D, Punaro MG, Chira P, Gottlieb BS, Higgins GC, Ilowite NT, Kimura Y, Hamilton S, Johnson A, Huang B, Lovell DJ; Childhood Arthritis and Rheumatology Research Alliance.

Arthritis Rheum. 2012 Jun;64(6):2012-21. doi: 10.1002/art.34343. Epub 2011 Dec 19.

23.

Primary lyme arthritis of the pediatric hip.

Glotzbecker MP, Kocher MS, Sundel RP, Shore BJ, Spencer SA, Kasser JR.

J Pediatr Orthop. 2011 Oct-Nov;31(7):787-90. doi: 10.1097/BPO.0b013e31822f1abc.

PMID:
21926878
24.

Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study.

Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW.

J Pediatr. 2011 Apr;158(4):644-649.e1. doi: 10.1016/j.jpeds.2010.10.012. Epub 2010 Dec 3.

PMID:
21129756
25.

Musculoskeletal causes of pediatric chest pain.

Son MB, Sundel RP.

Pediatr Clin North Am. 2010 Dec;57(6):1385-95. doi: 10.1016/j.pcl.2010.09.011. Review.

PMID:
21111123
26.

Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort.

Tory HO, Zurakowski D, Sundel RP.

J Rheumatol. 2010 May;37(5):1049-55. doi: 10.3899/jrheum.090711. Epub 2010 Apr 1.

PMID:
20360182
27.

Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease.

Yellen ES, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri JM, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW.

Pediatrics. 2010 Feb;125(2):e234-41. doi: 10.1542/peds.2009-0606. Epub 2010 Jan 25.

28.

Editorial: Do no harm--first but not only.

Sundel RP.

Curr Opin Rheumatol. 2009 Sep;21(5):531-2. doi: 10.1097/BOR.0b013e32832f82af. No abstract available.

PMID:
19617835
29.

Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006.

Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, Newburger JW.

Pediatrics. 2009 Jul;124(1):1-8. doi: 10.1542/peds.2008-0730.

PMID:
19564276
30.

Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.

Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP.

Arthritis Rheum. 2009 Jun;60(6):1825-1830. doi: 10.1002/art.24571.

31.

MRI findings of juvenile psoriatic arthritis.

Lee EY, Sundel RP, Kim S, Zurakowski D, Kleinman PK.

Skeletal Radiol. 2008 Nov;37(11):987-96. doi: 10.1007/s00256-008-0537-1. Epub 2008 Jul 2.

PMID:
18594809
32.

Chronic minocycline-induced autoimmunity in children.

El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, Dedeoglu F.

J Pediatr. 2008 Sep;153(3):314-9. doi: 10.1016/j.jpeds.2008.03.013. Epub 2008 Apr 28.

PMID:
18534244
33.

Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis.

Stoll ML, Lio P, Sundel RP, Nigrovic PA.

Arthritis Rheum. 2008 Jan 15;59(1):51-8. doi: 10.1002/art.23240.

34.

Gene-expression patterns reveal underlying biological processes in Kawasaki disease.

Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP, Brown PO, Burns JC, Relman DA.

Genome Biol. 2007;8(12):R261.

35.

Delayed diagnosis of Kawasaki disease: what are the risk factors?

Minich LL, Sleeper LA, Atz AM, McCrindle BW, Lu M, Colan SD, Printz BF, Klein GL, Sundel RP, Takahashi M, Li JS, Vetter VL, Newburger JW; Pediatric Heart Network Investigators.

Pediatrics. 2007 Dec;120(6):e1434-40. Epub 2007 Nov 19.

PMID:
18025079
36.

Vasculitis in children.

Dedeoglu F, Sundel RP.

Rheum Dis Clin North Am. 2007 Aug;33(3):555-83.

PMID:
17936177
37.

Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever.

Miyake CY, Gauvreau K, Tani LY, Sundel RP, Newburger JW.

Pediatrics. 2007 Sep;120(3):503-8.

PMID:
17766522
38.

Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.

El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.

J Pediatr. 2007 Apr;150(4):376-82.

PMID:
17382113
39.

Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP; Pediatric Heart Network Investigators.

N Engl J Med. 2007 Feb 15;356(7):663-75.

40.

Patients with juvenile psoriatic arthritis comprise two distinct populations.

Stoll ML, Zurakowski D, Nigrovic LE, Nichols DP, Sundel RP, Nigrovic PA.

Arthritis Rheum. 2006 Nov;54(11):3564-72.

41.

Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis.

Binstadt BA, Levine JC, Nigrovic PA, Gauvreau K, Dedeoglu F, Fuhlbrigge RC, Weindling SN, Newburger JW, Sundel RP.

Pediatrics. 2005 Jul;116(1):e89-93. Epub 2005 Jun 1.

PMID:
15930186
42.

MRI features of Lyme arthritis in children.

Ecklund K, Vargas S, Zurakowski D, Sundel RP.

AJR Am J Roentgenol. 2005 Jun;184(6):1904-9.

PMID:
15908551
43.

Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease.

Burns JC, Shimizu C, Shike H, Newburger JW, Sundel RP, Baker AL, Matsubara T, Ishikawa Y, Brophy VA, Cheng S, Grow MA, Steiner LL, Kono N, Cantor RM.

Genes Immun. 2005 Aug;6(5):438-44.

44.

Vasculitis in children.

Dedeoglu F, Sundel RP.

Pediatr Clin North Am. 2005 Apr;52(2):547-75, vii. Review.

PMID:
15820379
45.

Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study.

Lehman TJ, Schechter SJ, Sundel RP, Oliveira SK, Huttenlocher A, Onel KB.

J Pediatr. 2004 Dec;145(6):856-7.

PMID:
15580219
46.

Rituximab therapy for multisystem autoimmune diseases in pediatric patients.

Binstadt BA, Caldas AM, Turvey SE, Stone KD, Weinstein HJ, Jackson J, Fuhlbrigge RC, Sundel RP.

J Pediatr. 2003 Nov;143(5):598-604. Erratum in: J Pediatr. 2004 Apr;144(4):558.

PMID:
14615729
47.

Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.

Sundel RP, Baker AL, Fulton DR, Newburger JW.

J Pediatr. 2003 Jun;142(6):611-6.

PMID:
12838187
48.

Raynaud's phenomenon in children: a retrospective review of 123 patients.

Nigrovic PA, Fuhlbrigge RC, Sundel RP.

Pediatrics. 2003 Apr;111(4 Pt 1):715-21.

PMID:
12671102
49.

Physical and psychosocial health in children who have had Kawasaki disease.

Baker AL, Gauvreau K, Newburger JW, Sundel RP, Fulton DR, Jenkins KJ.

Pediatrics. 2003 Mar;111(3):579-83.

PMID:
12612239
50.

Fibroblastic rheumatism: case report and review of the literature.

Lee JM, Sundel RP, Liang MG.

Pediatr Dermatol. 2002 Nov-Dec;19(6):532-5. Review.

PMID:
12437558

Supplemental Content

Loading ...
Support Center